Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
PBYIthis companyPuma Biotechnology, Inc.	$8.39	9.6×	2.28×	1.3×	5.56×	61.0%	74.5%	16.3%	13.6%	23.9%	20.4%	14.0%	0.22×	-0.02×	5.63×	2×	0.0%	7	-1.09	4	A
AVBPArriVent BioPharma, Inc.	$13.65	-4.66×	2.52×	0×	-4.38×	-92.2%	0.0%	0.0%	0.0%	-54.1%	-57.8%	-20.8%	0×	0.27×	0×	12.83×	0.0%	2	12.15	2	C+
BDTXBlack Diamond Therapeutics, Inc.	$1.76	6.23×	1.23×	1.97×	5.99×	520.8%	99.5%	28.4%	32.0%	19.9%	15.2%	21.4%	0.17×	-0.1×	0×	8.42×	0.0%	1	-3.44	3	B-
CRDFCardiff Oncology, Inc.	$0.80	-4.07×	4.14×	316.73×	-3.81×	-96.7%	100.0%	-8256.3%	-7732.0%	-101.0%	-105.9%	-20.2%	0.02×	0.37×	0×	3.67×	0.0%	2	-16.02	2	C
MGNXMacroGenics, Inc.	$2.38	-1.36×	1.83×	0.68×	-2.54×	-2714.5%	71.1%	-48.7%	-49.9%	-134.2%	-33.0%	-81.6%	1.92×	-0.83×	-8.56×	5.1×	0.0%	1	-4.43	1	D+
NBPNovaBridge Biosciences	$0.94	-25.22×	5.02×	0×	-10.78×	-89.9%	0.0%	0.0%	0.0%	-20.0%	-40.2%	-12.4%	0.01×	2.35×	0×	8.09×	0.0%	1	7.97	2	C+
Peer median	—	-4.07×	2.52×	0.68×	-3.81×	-92.2%	71.1%	0.0%	0.0%	-54.1%	-40.2%	-20.2%	0.02×	0.27×	0×	8.09×	0.0%	1	-3.44	2	—